McKesson Ventures’ Carrie Williams Speaks at 2023 DHIS Conference
McKesson Ventures Vice President & Partner Carrie Williams spoke at the Digital Healthcare Innovation Summit, East Coast, which took place June 6 and 7, 2023, in Boston.
Williams participated in a panel discussion titled “Beyond the Clinic: Digital & Home-Based Models to Close Gaps, Improve Outcomes & Delight consumers.” Innovations in digital healthcare are creating unprecedented opportunities to improve the business of healthcare while also increasing consumer satisfaction and quality of care. The roundtable discussion addressed questions like:
- What are examples of innovations in home-based digital care that have potential to improve consumers’ future?
- What are the key strategic considerations as we anticipate the end of the COVID-19 public health emergency?
- How are health plans and “payviders” ensuring continuity of care?
- How can hybrid care programs hurt your health equity program, and how can they help?
The panel was moderated by Christopher Booker, Partner, First Cressey Ventures. The other panelists were Joe Kimura, CMO, Somatus; Tom Olenzak, Managing Director, Cigna Ventures; and Pippa Shulman, DO, CMO, Medically Home.
The Digital Healthcare Innovation Summit (DHIS) is an annual gathering of the leading innovators, investors, payers, providers, and policymakers who are helping to revolutionize healthcare. This year, the DHIS focused on timely topics such as direct-to-consumer healthcare, underserved populations, important regulatory or policy changes, distributed vs. centralized care, women’s health, infrastructure as a service (IaaS) and the Internet of Things (IOT) in healthcare, and more. The speakers draw from their own experiences to share content that will benefit the rest of the audience.
Carrie Williams joined McKesson Ventures in 2017. Prior to that, she served as vice president, strategy and business development for Omada Health, where she focused heavily on all elements of commercial strategy and partnerships. She also held roles within McKesson’s strategy and business development team, working to advance strategies aimed at innovation within hospital pharmacy and clinical trial patient recruitment. Some of Williams’ investments at MV include Evidation Health, Xealth, Tact.ai, and Propeller Health (acquired by ResMed).
Willams holds an MBA from the Haas School of Business at the University of California at Berkeley, and a BS in biology from the University of Massachusetts Amherst.
Learn more about the DHIS East Coast conference here.
The next DHIS West Coast conference will take place February 6-7, 2024. Learn more here.